Delivery Order SPE2DR25D2006-SPE2DR26F56UE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packages of 30 units. This firm fixed-price delivery order, valued at $1,889.91, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a $1,207.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30 count). The contract, with an ultimate completion date of December 10, 2025, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,583.92 to supply Micardis HCT 80-25 mg tablets in unit dose packaging of 30 units. The contract, which is non-competitive and firm fixed price, was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,933.79 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (30 unit dose packages) with a completion date of November 18, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,044.82 to supply Micardis HCT 80-25 mg tablet unit dose packages (30 count) with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,118.82 to AmerisourceBergen Drug Corp for Micardis HCT 80-25 mg tablets (unit dose, 30-count packaging) with a firm fixed price structure. This contract, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a competitively awarded procurement with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,093.19 to supply Micardis HCT 80-25 mg tablets (undivided 30 count) with a firm fixed price structure. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of December 5, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Micardis HCT 80-25 mg tablet unit dose packages (30-count) with a ceiling value of $2,217.60. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packages of 30 units, with a ceiling value of $1,385.99. This is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,990.86 to supply Micardis HCT 80-25 mg tablet unit dose packs (30 count) with an ultimate completion date of December 3, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitive delivery order under AmerisourceBergen's existing federal supply agreements. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56UEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,659.44 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30-count). This firm fixed-price contract, which is not set-aside designated, calls for delivery by December 16, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds an extensive portfolio of federal contracts with the Defense Logistics Agency covering a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's ongoing role in supplying brand-name pharmaceutical products to support defense health programs and demonstrates the operational flexibility of the global pharmaceutical prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/14/25 |